The signalling pathways controlling both the evolution and development of language in the human brain remain unknown. So far, the transcription factor FOXP2 (forkhead box P2) is the only gene implicated in Mendelian forms of human speech and language dysfunction 1-3 . It has been proposed that the amino acid composition in the human variant of FOXP2 has undergone accelerated evolution, and this two-amino-acid change occurred around the time of language emergence in humans 4,5 . However, this remains controversial, and whether the acquisition of these amino acids in human FOXP2 has any functional consequence in human neurons remains untested. Here we demonstrate that these two human-specific amino acids alter FOXP2 function by conferring differential transcriptional regulation in vitro. We extend these observations in vivo to human and chimpanzee brain, and use network analysis to identify novel relationships among the differentially expressed genes. These data provide experimental support for the functional relevance of changes in FOXP2 that occur on the human lineage, highlighting specific pathways with direct consequences for human brain development and disease in the central nervous system (CNS). Because FOXP2 has an important role in speech and language in humans, the identified targets may have a critical function in the development and evolution of language circuitry in humans.
The signalling pathways controlling both the evolution and development of language in the human brain remain unknown. So far, the transcription factor FOXP2 (forkhead box P2) is the only gene implicated in Mendelian forms of human speech and language dysfunction [1] [2] [3] . It has been proposed that the amino acid composition in the human variant of FOXP2 has undergone accelerated evolution, and this two-amino-acid change occurred around the time of language emergence in humans 4, 5 . However, this remains controversial, and whether the acquisition of these amino acids in human FOXP2 has any functional consequence in human neurons remains untested. Here we demonstrate that these two human-specific amino acids alter FOXP2 function by conferring differential transcriptional regulation in vitro. We extend these observations in vivo to human and chimpanzee brain, and use network analysis to identify novel relationships among the differentially expressed genes. These data provide experimental support for the functional relevance of changes in FOXP2 that occur on the human lineage, highlighting specific pathways with direct consequences for human brain development and disease in the central nervous system (CNS). Because FOXP2 has an important role in speech and language in humans, the identified targets may have a critical function in the development and evolution of language circuitry in humans.
The amino acid structure of FOXP2 had been highly conserved along the mammalian lineage until the common ancestor of humans and chimpanzees, when the human variant of FOXP2 acquired two different amino acids under positive selection, which has been interpreted as evidence for accelerated evolution 4, 5 . To test whether the amino acids under positive selection in human FOXP2 have a distinct biological function, which would support the role of these changes in evolution, we expressed either human FOXP2 or the same construct mutated at two sites to yield the chimpanzee amino acid content, FOXP2 chimp , in human neuronal cells without endogenous FOXP2 ( Fig. 1a-f ). Exogenous FOXP2 protein expressed from both constructs was localized in the nucleus as determined by immunocytochemistry ( Fig. 1c-e ) and subcellular fractionation ( Fig. 1f ), consistent with its endogenous expression. To determine if modifying two amino acids leads to changes in gene expression, we conducted whole-genome microarray analysis. We identified 61 genes significantly upregulated and 55 genes downregulated by FOXP2 compared to FOXP2 chimp ( Supplementary Table 1) , as well as genes regulated by both FOXP2 and FOXP2 chimp ( Supplementary Table 2 ). Notably, FOXP2 chimp overexpression resulted in more changes in gene regulation than FOXP2 ( Supplementary Table 3 ). In replicate experiments in a different human neuronal cell line, FOXP2 chimp again regulated more genes than FOXP2 even though its expression was higher than FOXP2 in these cells (data not shown). To control for any potential confounding effects of FOXP2 levels, we performed correlations of the levels of every gene on the array to either FOXP2 or FOXP2 chimp levels, as well as performing random permutation testing, and found no significant differences between other genes' correlations to either FOXP2 or FOXP2 chimp . These data indicate that the differentially expressed genes are not due to different levels of FOXP2 or FOXP2 chimp , and are a true indication of differential transcriptional regulation by these two proteins.
To confirm the validity of differentially expressed FOXP2 target genes, we conducted quantitative polymerase chain reaction following reverse transcription (qRT-PCR) using independent RNA samples. We confirmed 93% of the FOXP2 upregulated genes and 75% of the downregulated genes examined (Fig. 1g, h and Supplementary Fig. 1 ). Five genes confirmed by qRT-PCR (COL9A1, ROR2, SLIT1, SYK, and TAGLN; Fig. 1g , h and Supplementary Fig. 1 ) were previously identified as direct FOXP2 targets using ChIP-chip 6, 7 . Sixty per cent of promoters of the identified differentially expressed genes have at least one canonical FOXP2 binding site, 92% have at least one forkhead domain binding site, and 99% have at least one 'core' FOXP2 binding site ( Supplementary Table 4 ). The canonical FOXP2 binding site CAAATT, as well as the core site AAAT, is significantly enriched in the downregulated genes (P 5 3.3 3 10 24 and P 5 8.6 3 10 23 , respectively) compared to randomly permuting the same number of promoters from the genome. Genes with promoters containing a canonical FOXP2 binding site are likely to be direct FOXP2 or FOXP2 chimp targets.
To confirm that these findings were not an artefact of the cell lines used, we further assessed whether a different primary neural cell, human neural progenitors, would show similar differential regulation by FOXP2 and FOXP2 chimp . We confirmed one-third of the genes examined in these human cells using both a different method of gene transduction, and populations of cells with greater levels of FOXP2 chimp compared to human FOXP2 overexpression, which complements the SH-SY5Y data to further show that the observed relationships are not due to FOXP2 levels ( Supplementary Fig. 2 ). As an additional level of validation and to extend the findings to the level of protein, we confirmed two genes, CACNB2 and ENPP2, by immunoblotting in additional SH-SY5Y cell lines ( Supplementary Fig. 3 ).
To explore the potential function of the differential FOXP2 targets, we determined enrichment of gene ontology (GO) categories. GO categories enriched for genes upregulated by FOXP2 compared to FOXP2 chimp are involved in transcriptional regulation of gene expression and cell-cell signalling. Those GO categories enriched for genes downregulated by FOXP2 compared to FOXP2 chimp are important for protein and cell regulation (Supplementary Table 5 ).
These data support the idea that FOXP2 and FOXP2 chimp have distinguishable downstream effects as reflected by their differences in gene regulation.
To determine the potential mechanisms by which FOXP2 or FOXP2 chimp might differentially regulate gene expression, we first examined whether either protein preferentially interacts with FOXP1 or FOXP4, two proteins known to form a heterodimer with Supplementary Fig. 4b-g ), ruling out a major difference in FOXP1 or FOXP4 interaction causing differential gene expression. Mass spectrometry showed no significant difference in either co-immunoprecipitation experiment, indicating that differences in hetero-or homodimerization did not underlie the observed differences in gene expression between the chimpanzee and human FOXP2. We also tested whether changes in cell proliferation could account for gene expression differences, but did not find significant changes in growth with either FOXP2 construct ( Fig. 2c ).
We next assessed whether FOXP2 and FOXP2 chimp expression led to differential promoter transactivation of target genes. We selected eight genes confirmed by qRT-PCR that also contained at least one forkhead binding site (Supplementary Table 6 ). Six of the promoters tested showed differential regulation by FOXP2 compared to FOXP2 chimp in the same direction as the microarrays (Fig. 2d, e ), whereas two did not demonstrate significant transactivation in either direction (data not shown). In contrast, a canonical FOXP2 binding site in triplicate alone, outside of a genomic context, was regulated equally by both FOXP2 and FOXP2 chimp ( Supplementary Fig. 5 ). Given the complexity of cis-acting gene transactivation elements, these data are particularly compelling considering our use of simplified 59 promoter regions. These data demonstrate that at least a subset of differentially regulated genes is also differentially transactivated by FOXP2 and FOXP2 chimp , indicating that they are probably direct FOXP2 targets.
To place these gene expression changes within a more systematic context, we applied weighted gene co-expression network analysis 9,10 to the entire SH-SY5Y microarray data set to examine co-regulation of gene expression across all genes. We uncovered two modules where the module eigengene (for definition, see Methods) was driven by differences in FOXP2 and FOXP2 chimp , and one module driven by similar gene regulation ( Fig. 3 and Supplementary Fig. 6 ). Using this unsupervised analysis, we found additional genes of interest that do not meet the criteria for differential expression, but that are co-regulated with differences in FOXP2 and FOXP2 chimp expression ( Supplementary  Table 7 ). Notably, two of the genes with the most connections, so-called 'hub' genes, in one of the differential networks are DLX5 and SYT4, two genes important for brain development and function 11, 12 .
To extrapolate these findings to true in vivo expression and provide external validation, we compared the differentially expressed genes in SH-SY5Y cells to differentially expressed genes from adult human and chimpanzee brain tissue. We performed microarray analysis on tissue from three brain regions where FOXP2 is expressed in developing brain: caudate nucleus, frontal pole and hippocampus. We examined gene expression in human compared to chimpanzee for each brain region separately as well as for all brain regions combined, for a total of eight comparisons. There was a significant overlap in seven out of eight of these comparisons, a remarkable convergence with the in vitro data ( Table 1 ). These data are particularly notable, as the tissue was from adult brain. We surmise that a subset of the overlapping differentially expressed genes found in adult brain is the result of differential functions by FOXP2 in the developing brain, and may lead to increased vulnerability to disease. For example, mutations in both FGF14 and PPP2R2B lead to spinocerebellar ataxia (spinocerebellar ataxia type 27 and 12, respectively), which involves motor-related speech defects 13, 14 . Because both of these genes have a critical role in cerebellar function, it is of note that patients with FOXP2 mutations have decreased grey matter in the cerebellum 15 , and Foxp2 knockout mice have their most pronounced morphological phenotype in the cerebellum 16 . Mutations in COL9A1 lead to Stickler syndrome in which patients have craniofacial abnormalities 17 , and patients with mutations in GJA12 (also called GJC2) present with ataxia, nystagmus, other motor impairments, and often mental retardation 18 .
Although comparisons of developing brain between human and chimpanzee are challenged by a lack of tissue, a recent study examined gene expression in many regions of human fetal brain 19 . Comparing the list of 116 differentially expressed genes with those focally expressed during human fetal development, we find 14 genes specifically expressed in one brain region, including FOXP2 (Supplementary Table 8 ). Two regions of the human fetal brain with high FOXP2 expression 19 -perisylvian cortex and cerebellum-have a significant number of enriched genes that overlap with the differentially expressed FOXP2 and FOXP2 chimp genes (P 5 1.1 3 10 24 and P 5 1.3 3 10 24 , respectively; Supplementary Table 8 ). A significant number of the differentially expressed genes are also associated with human-specific accelerated highly conserved non-coding sequences (haCNS), but not with chimpanzee highly conserved non-coding sequences (P 5 1.2 3 10 26 and P 5 0.04; Supplementary Table 8 ) 19, 20 . We confirmed a number of these genes, such as GRM8, MAOB, PPP2R2B, PRICKLE1 and RUNX1T1, either by qRT-PCR and/or with the adult in vivo data set ( Fig. 1 and Table 1 ). Together, these data suggest that the FOXP2 differentially expressed genes identified here may have important roles in brain development and patterning, and may also have evolved cis-regulatory elements important for their expression specifically in human brain.
Previously, we identified ChIP-chip targets of FOXP2 that themselves were also under positive selection 6 . We hypothesized that networks of genes important for language circuitry had been positively selected through selective pressure on human brain evolution. Thus, we also examined whether any differential FOXP2 targets were themselves Supplementary Table 9) 21 . These data, along with the haCNS and expression data mentioned above, suggest that a subset of differential FOXP2 targets may have co-evolved to regulate pathways involved in higher cognitive functions.
The positive selection of two amino acids in human FOXP2 was previously hypothesized as a mechanism by which human FOXP2 might assume a novel biological function with implications for speech and language evolution 4, 5 . A recent study made an elegant attempt to examine the role of these two amino acids by generating a transgenic mouse with the human version of FOXP2 (ref. 22) . These mice show a number of interesting phenotypic alterations including increases in dendritic length in striatal neurons and changes in ultrasonic vocalizations, as well as some modest changes in gene expression. Although the mouse is an experimentally tractable model system, from a strictly evolutionary standpoint, the interpretation of data obtained in the mouse specifically for the study of human evolution is challenged by the vast differences in human and mouse brain and the amount of time since the human and mouse common ancestor diverged (70 million years 23 ). Here, we demonstrate that these two amino acid changes have a functional consequence in human cells, validate these differences in vivo in tissue, and elucidate some of the downstream pathways affected by this adaptive evolutionary change.
Using whole-genome microarrays, we uncovered genes that are differentially regulated upon mutation of these two amino acids, including some with functions critical to the development of the human central nervous system. Moreover, this study reveals enrichment of differential FOXP2 targets with known involvement in cerebellar motor function, craniofacial formation, and cartilage and connective tissue formation, suggesting an important role for human FOXP2 in establishing both the neural circuitry and physical structures needed for spoken language. The significant overlap of human FOXP2 targets in cell lines with genes enriched in human compared to chimpanzee brain tissue presents the possibility that human and chimpanzee FOXP2 have differentially regulated targets during brain development. As suggested over 30 years ago 24 , and reaffirmed by the sequencing of both the human and chimpanzee genomes, the phenotypic differences exhibited by humans and chimpanzees cannot be explained by differences in DNA sequence alone, and are probably due to differences in gene expression and regulation. Previous microarray studies identified differences in gene expression between human and chimpanzee brains 25, 26 . Here, we link new whole-genome expression microarray data from human and chimpanzee brain to direct differences in gene regulation by the human and chimpanzee version of the transcription factor FOXP2. Because normal FOXP2 function is critical for speech in humans, these differentially regulated targets may be relevant to the evolution and establishment or function of pathways necessary for speech and language in humans.
METHODS SUMMARY
Cell culture and stable line generation. SH-SY5Y cells (ATCC) and human fetal neuronal progenitors (Lonza) were grown according to the manufacturer's instructions, with some modifications (see Methods). Microarrays. Total RNA was extracted using Qiagen's RNeasy kit. Illumina HumanRef-8 v2 (SH-SY5Y samples) or v3 (tissue samples) were used and analysed as described 27 . Sample information is in Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Antibodies. The following antibodies were either used for immunoblotting (IB) or immunofluorescence (IF): anti-Flag (mouse monoclonal, Sigma; 1:10,000 (IB), 1:10,000 (IF)), anti-GAPDH (mouse monoclonal, Chemicon; 1:2500 (IB)), anti-b-tubulin (rabbit polyclonal, Abcam; 1:1000 (IB)), anti-FOXP1 (ref. 6; 1:5000 (IB), 1:1000 (IF)), anti-CACNB2 (mouse monoclonal, Abcam; 1:100 (IB)), anti-ENPP2 (rabbit polyclonal, Cayman Chemical; 1:400 (IB)), goat anti-rabbit horseradish peroxidase (Cell Signaling, 1:2,500), goat anti-mouse horseradish peroxidase (Chemicon, 1:5,000), goat anti-mouse Alexa Fluor 488 (Invitrogen, 1:1,500), goat anti-rabbit Alexa Fluor 594 (Invitrogen, 1:1,500) . Cell culture and stable line generation. Stable SH-SY5Y cell lines were generated by transfecting cells with pCMV-Tag4a expression constructs using FuGENE (Roche Applied Science) according to the manufacturer's instructions. Populations of stable cells were selected using 1 mg ml 21 geneticin (Invitrogen). Multiple independent lines were generated from independent transfections. Stable human fetal neuronal progenitor cell lines were generated by transducing cells with lentiviruses as previously described 28 . FOXP2-producing lentiviral vectors were generated by replacing the eGFP in pLUGIP (ATCC) with FOXP2. Immunoprecipitation. Nuclear extract was incubated with either 1 mg of Flag antibody (Sigma) or a polyclonal FOXP1 antibody 6 . Cell proliferation assay. Equal numbers of cells (2.0 3 10 4 ) were plated on time zero and counted every subsequent day after trypsinization using a haemacytometer. Dual luciferase assays. 293T cells (ATCC) were transfected with 50 ng of reporter construct expressing Photinus pyralis (firefly) luciferase, 1 ng of Renilla luciferase plasmid (pRL-EF), and 50 ng of pCMV-Tag4a FOXP2 expression plasmid using FuGENE (Roche Applied Science) according to the manufacturer's instructions. Forty-eight hours later, cells were lysed and analysed using the dual luciferase reporter assay system (Promega) according to the manufacturer's instructions. Co-transfection of Renilla was used for transfection normalization, and values were additionally normalized to cells transfected with a promoter-less luciferase construct. Promoter information is in Supplementary  Table 6 . The canonical FOXP2 binding site driving luciferase was generated by cloning AATTTG in triplicate into pGL4 (Promega). Gene ontology analysis. GO analysis was performed as described 6 using DAVID (http://david.abcc.ncifcrf.gov). The differentially expressed genes were compared to all of the genes on the microarrays and a P value computed using a Fisher's exact test.
Immunoblotting. Whole-cell protein lysates were generated and immunoblotted as described 28 .
Immunofluorescence. Cells were grown on glass coverslips, fixed in 2% paraformaldehyde, and permeabilized in 0.2% Triton X-100. TBST containing 10% milk and 10% normal goat serum was used as blocking solution at room temperature for 1 h. Antibodies were diluted in TBS with 0.25% BSA, 0.25% normal goat serum and 0.1% Triton X-100 and applied to cells overnight at 4 uC. Secondary antibodies were diluted in blocking solution and added at room temperature for 1 h. Coverslips were mounted to glass slides and images taken using a Zeiss Axio Imager D1. Mass spectrometry. FOXP2 immunoprecipitates were precipitated by the addition of trichloroacetic acid and proteolysed by the sequential addition of Lys-C and trypsin proteases 29 . Digested peptide samples were then analysed by mass spectrometry as described 29 . Proteins were considered to be present in a sample if at least two peptides per protein were identified using a false positive rate of less than 5% per peptide as determined using a decoy database strategy 30 . Microarrays. For the SH-SY5Y data, we analysed four biological replicates of each genotype from three independently generated cell lines for a total of 12 microarrays per genotype. Each of these cell lines was created from populations of cells rather than single clones, and as such, the expression data represent changes from hundreds of independent integrations throughout the cells' genomes. Furthermore, as the endogenous FOXP2 expression is very low in SH-SY5Y cells, the potential confound of heterodimerization with endogenous human FOXP2 is mitigated in these cells. For the tissue data, we analysed three to six independent samples for each brain region in each species. Detailed code for the microarray analysis is available 31 . Permutation testing. For FOXP2 correlations, we computed the average correlation for each gene on the microarray to either the level of the human or the chimpanzee FOXP2. We then derived the absolute difference in correlation for each gene between the human and chimpanzee FOXP2 arrays. The average of these differences was not statistically different from performing the same test while randomizing the correlation values for all of the genes on the arrays, or using the values from only the differentially expressed genes. For promoter binding site calculations, we calculated the number of promoters from differentially expressed genes with a given motif and compared them to the average number from a random selection of the same number of promoters from the genome. We assumed a normal distribution and a Z-score less than 0.05 was called significant. Similar analysis was done for comparing genes with a haCNS and expression in human fetal brain. For microarray overlap comparisons, we included the number of differentially expressed genes as well as the total number of probe sets on the microarrays for each comparison. We used a hypergeometric distribution test with 10,000 permutations to calculate the mean and standard deviation of the overlap. We assumed a normal distribution, and a Z-score less than 0.05 was called significant. Real-time PCR. RNA extraction and RT-PCR was performed as described 6 . Primer sequences are in Supplementary Table 10 . Site-directed mutagenesis. Mutagenesis of pCMV-Tag4a/FOXP2 6 was carried out using the GeneTailor Site-Directed Mutagenesis System (Invitrogen) according to the manufacturer's instructions using the following primers: site 1 (asparagine to threonine), F-59-CCTCCTCGACTACCTCCTCCACAACTTCC AAAGC-39, R-59-GGAGGAGGTAGTCGAGGAGGAATTGTTAGTA-39; site 2 (serine to asparagine), F-59-ATGGACAGTCTTCAGTTCTAAACGCAAGACG AGA-39, R-59-TAGAACTGAAGACTGTCCATTCACTATGGAA-39. Mutagenesis was confirmed by both sequencing and mass spectrometry. Weighted gene coexpression network analysis (WGCNA). WGCNA was performed as previously described 9, 10 . Briefly, genes were chosen for inclusion into the network on the basis of their consistent presence on the array and high coefficient of variation, and they were clustered based on their topological overlap. For each module, singular value decomposition (X 5 UDV') was performed, and the expression was re-calculated without the first principal component because it corresponded to cell line differences. The modules reported in this study were created using expression data with the first principal component removed, as it represented an experimental batch effect.
